- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/26 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones
Patent holdings for IPC class C07K 16/26
Total number of patents in this class: 936
10-year publication summary
82
|
82
|
69
|
94
|
71
|
72
|
63
|
62
|
60
|
27
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
H. Lundbeck A/S | 1234 |
37 |
Adrenomed AG | 43 |
27 |
Eli Lilly and Company | 3832 |
20 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2799 |
19 |
Amgen Inc. | 4071 |
17 |
Regeneron Pharmaceuticals, Inc. | 4242 |
17 |
Progastrine et Cancers S.A R.L. | 24 |
17 |
Centre National de La Recherche Scientifique | 10408 |
15 |
Teva Pharmaceuticals International GmbH | 324 |
15 |
F. Hoffmann-La Roche AG | 7934 |
12 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3365 |
12 |
Intrinsic Lifesciences LLC | 16 |
10 |
Les Laboratoires Servier | 545 |
10 |
Merus N.V. | 211 |
10 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2842 |
10 |
Roche Diagnostics Operations, Inc. | 1483 |
9 |
Board of Regents, The University of Texas System | 5763 |
9 |
AlderBio Holdings LLC | 23 |
9 |
B.r.a.h.m.s GmbH | 178 |
9 |
Universitat Ulm | 108 |
9 |
Other owners | 643 |